Ropes and Gray: Teva and Samsung Bioepis Expand Global Collaboration to Advance Up to Six Biosimilar Candidates
October 06, 2026
October 06, 2026
BOSTON, Massachusetts, Oct. 6 -- Ropes and Gray, a law firm, issued the following news:
* * *
Teva and Samsung Bioepis Expand Global Collaboration to Advance up to Six Biosimilar Candidates
October 5, 2026
Ropes & Gray advised Teva Pharmaceutical Industries in a global license, development and commercialization agreement with Samsung Bioepis Co. for up to six potential biosimilar candidates. The deal was announced on October 1 and financial . . .
* * *
Teva and Samsung Bioepis Expand Global Collaboration to Advance up to Six Biosimilar Candidates
October 5, 2026
Ropes & Gray advised Teva Pharmaceutical Industries in a global license, development and commercialization agreement with Samsung Bioepis Co. for up to six potential biosimilar candidates. The deal was announced on October 1 and financial . . .